“…When discussing ASP, it is important to differentiate between radiographical ASP, which is radiographical evidence of degeneration at the levels adjacent to a previous fusion, and clinical ASP (CASP), which is the development of clinically relevant symptoms (i.e., radiculopathy and/ or myelopathy) that correlate with radiographical evidence of degeneration that is adjacent to a previous fusion [ 2 ]. The prevalence of CASP during the current follow up periods of 4.5 years and 21 years are 25%-89% [ 3 , 4 , 5 ] and 7%-15%, respectively [ 1 , 6 , 7 , 8 ]. Several factors have been associated with the development of ASP, such as the number and location of fusion segments, age, and pre-existing degenerative changes at adjacent segments [ 4 , 9 , 10 ].…”